Literature DB >> 16883009

Prognostic stratification of obese patients by stress 99mTc-tetrofosmin myocardial perfusion imaging.

Abdou Elhendy1, Arend F L Schinkel, Ron T van Domburg, Jeroen J Bax, Roelf Valkema, Elena Biagini, Don Poldermans.   

Abstract

UNLABELLED: Obesity is a major heath problem associated with increased cardiovascular mortality. There are currently no data to support a role for stress imaging techniques in the risk stratification of obese patients. The aim of this study was to assess the independent value of stress 99mTc-tetrofosmin SPECT in predicting mortality and hard cardiac events in obese patients.
METHODS: We studied 265 patients with a body mass index greater than 30 kg/m2 by exercise or dobutamine stress 99mTc-tetrofosmin myocardial perfusion tomography. Endpoints during follow-up were cardiac death and death of any cause.
RESULTS: The mean patient age (+/-SD) was 59 +/- 10 y, and 110 of the patients were men (42%). The mean body mass index was 37 +/- 7 kg/m2. Scan findings were normal in 113 patients (43%). Myocardial perfusion abnormalities were fixed in 62 patients (23%) and reversible in 90 patients (34%). During a mean follow-up period of 5.5 +/- 2 y, 41 patients (15%) died. Death was considered cardiac in 22 patients (8%). Nonfatal myocardial infarction occurred in 20 patients (7.5%). The annual cardiac death rate was 0.6% in patients with normal perfusion and 3.3% in patients with abnormal perfusion. Patients with a multiple-vessel distribution of abnormalities had a higher cardiac death rate than did patients with a single-vessel distribution (4.1% vs. 2.5%, P < 0.05). The annual mortality rate was 1.3% in patients with normal perfusion and 4.2% in patients with abnormal perfusion. In a multivariate analysis, perfusion abnormalities were independently predictive of cardiac mortality (risk ratio, 3.2; 95% confidence interval, 1.5-6.7) and overall mortality (risk ratio, 2.7; 95% confidence interval, 1.4-4.3).
CONCLUSION: Stress 99mTc-tetrofosmin myocardial perfusion imaging is a useful tool for predicting cardiac and overall mortality in obese patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16883009

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

2.  Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity.

Authors:  David T Harnett; Samir Hazra; Ronnen Maze; Brian A Mc Ardle; Ali Alenazy; Trevor Simard; Ellen Henry; Girish Dwivedi; Christopher Glover; Robert A deKemp; Ross A Davies; Terrence D Ruddy; Benjamin J W Chow; Rob S Beanlands; Benjamin Hibbert
Journal:  J Nucl Cardiol       Date:  2017-03-29       Impact factor: 5.952

3.  Gated single photon emission tomography MIBI stress perfusion imaging for assessing cardiac output and index in obese and non-obese patients.

Authors:  J P Coffey; J C Hill
Journal:  Ir J Med Sci       Date:  2007-11-20       Impact factor: 1.568

Review 4.  Challenges in cardiac risk assessment in bariatric surgery patients.

Authors:  David Gugliotti; Paul Grant; Wael Jaber; Loutfi Aboussouan; Charles Bae; Daniel Sessler; Philip Scahuer; Roop Kaw
Journal:  Obes Surg       Date:  2007-12-08       Impact factor: 4.129

5.  Vasodilator stress perfusion CMR imaging is feasible and prognostic in obese patients.

Authors:  Ravi V Shah; Bobak Heydari; Otavio Coelho-Filho; Siddique A Abbasi; Jiazhuo H Feng; Tomas G Neilan; Sanjeev Francis; Ron Blankstein; Michael Steigner; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2014-04-09

6.  What is the value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging for the assessment of very long-term outcome in obese patients?

Authors:  Rebecca S Korbee; Henk J Boiten; Machiel Ottenhof; Roelf Valkema; Ron T van Domburg; Arend F L Schinkel
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

7.  Study of Myocardial Perfusion in Obese Individuals without Known Ischemic Heart Disease.

Authors:  Tufi Dippe; Cláudio Leinig Pereira da Cunha; Rodrigo Julio Cerci; Arnaldo Lafitte Stier; João Vicente Vítola
Journal:  Arq Bras Cardiol       Date:  2018-12-17       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.